TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
BioEndev AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
|
1,336
|
313 |
Financial expenses |
77
|
90
|
73 |
Earnings before taxes |
3,109
|
-680
|
-7,092 |
EBITDA |
-125
|
-835
|
-7,020 |
Total assets |
3,507
|
22,420
|
36,410 |
Current assets |
3,235
|
21,418
|
35,320 |
Current liabilities |
77
|
2,948
|
8,302 |
Equity capital |
3,430
|
19,472
|
21,928 |
- share capital |
320
|
319
|
347 |
Employees (average) |
0
|
1
|
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
97.8%
|
86.9%
|
60.2% |
Turnover per employee |
1,336
|
156 | |
Profit as a percentage of turnover |
-50.9%
|
-2265.8% | |
Return on assets (ROA) |
90.8%
|
-2.6%
|
-19.3% |
Current ratio |
4201.3%
|
726.5%
|
425.4% |
Return on equity (ROE) |
90.6%
|
-3.5%
|
-32.3% |
Change turnover |
-1,343
|
1,048
|
-50 |
Change turnover % |
-100%
|
364%
|
-14% |
Chg. No. of employees |
-1
![]() |
-1
![]() |
-1 |
Chg. No. of employees % |
-100%
|
-50%
|
-33% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.